NM_000722.4:c.2126G>A

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000722.4(CACNA2D1):​c.2126G>A​(p.Ser709Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00332 in 1,588,146 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0023 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 13 hom. )

Consequence

CACNA2D1
NM_000722.4 missense

Scores

3
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.56
Variant links:
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008761466).
BP6
Variant 7-81971792-C-T is Benign according to our data. Variant chr7-81971792-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 416572.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-81971792-C-T is described in Lovd as [Benign]. Variant chr7-81971792-C-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 344 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D1NM_000722.4 linkc.2126G>A p.Ser709Asn missense_variant Exon 26 of 39 ENST00000356860.8 NP_000713.2 P54289-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D1ENST00000356860.8 linkc.2126G>A p.Ser709Asn missense_variant Exon 26 of 39 1 NM_000722.4 ENSP00000349320.3 P54289-2
CACNA2D1ENST00000443883.2 linkc.2162G>A p.Ser721Asn missense_variant Exon 26 of 39 5 ENSP00000409374.2 P54289-1H0Y715
CACNA2D1ENST00000705962.1 linkc.2006G>A p.Ser669Asn missense_variant Exon 25 of 38 ENSP00000516190.1 A0A994J595
CACNA2D1ENST00000705961.1 linkc.1892G>A p.Ser631Asn missense_variant Exon 24 of 37 ENSP00000516189.1 A0A994J5M8

Frequencies

GnomAD3 genomes
AF:
0.00227
AC:
344
AN:
151696
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000580
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000989
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00217
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00384
Gnomad OTH
AF:
0.00240
GnomAD3 exomes
AF:
0.00254
AC:
636
AN:
250464
Hom.:
2
AF XY:
0.00269
AC XY:
364
AN XY:
135412
show subpopulations
Gnomad AFR exome
AF:
0.000495
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.00379
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000458
Gnomad FIN exome
AF:
0.00342
Gnomad NFE exome
AF:
0.00391
Gnomad OTH exome
AF:
0.00361
GnomAD4 exome
AF:
0.00343
AC:
4926
AN:
1436332
Hom.:
13
Cov.:
27
AF XY:
0.00348
AC XY:
2490
AN XY:
716062
show subpopulations
Gnomad4 AFR exome
AF:
0.000577
Gnomad4 AMR exome
AF:
0.00121
Gnomad4 ASJ exome
AF:
0.00383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000550
Gnomad4 FIN exome
AF:
0.00337
Gnomad4 NFE exome
AF:
0.00398
Gnomad4 OTH exome
AF:
0.00323
GnomAD4 genome
AF:
0.00227
AC:
344
AN:
151814
Hom.:
0
Cov.:
32
AF XY:
0.00202
AC XY:
150
AN XY:
74212
show subpopulations
Gnomad4 AFR
AF:
0.000579
Gnomad4 AMR
AF:
0.000987
Gnomad4 ASJ
AF:
0.00260
Gnomad4 EAS
AF:
0.000387
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.00217
Gnomad4 NFE
AF:
0.00384
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.00400
Hom.:
1
Bravo
AF:
0.00238
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00547
AC:
47
ExAC
AF:
0.00268
AC:
325
Asia WGS
AF:
0.000289
AC:
1
AN:
3468

ClinVar

Significance: Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 03, 2022
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 23874304, 30027834, 27711072, 25527503, 23414114, 20817017, 26498160, 22840528, 26707467, 30821013) -

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Brugada syndrome Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Nov 10, 2021
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

CACNA2D1-related disorder Benign:1
Mar 27, 2019
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
22
DANN
Benign
0.97
DEOGEN2
Benign
0.041
.;T
Eigen
Benign
0.17
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.80
T;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.0088
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
.;N
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
0.86
N;N
REVEL
Benign
0.10
Sift
Benign
0.26
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0030
B;.
Vest4
0.15
MVP
0.11
MPC
0.43
ClinPred
0.011
T
GERP RS
5.2
Varity_R
0.094
gMVP
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs78086631; hg19: chr7-81601108; COSMIC: COSV62391757; COSMIC: COSV62391757; API